Weight-loss management

A comprehensive health check designed for individuals using medical weight-loss treatments such as Mounjaro and Ozempic. This profile monitors kidney and liver function, cholesterol levels, blood sugar control, and pancreatic enzymes to help ensure safe and effective long-term use of GLP-1 medications.

What can I expect from Weight-loss management?

Weight Loss Management Blood Test - For Users of Mounjaro, Ozempic & Other GLP-1 Medications

GLP-1 receptor agonists like Mounjaro (tirzepatide) and Ozempic (semaglutide) have revolutionised weight-loss and diabetes management. However, these medications can impact multiple organs and metabolic processes, making regular monitoring essential for long-term safety and effectiveness.

This comprehensive blood test profile is specifically designed for individuals using medical weight-loss injections. It provides key insights into how your body is responding to treatment by assessing:

• Kidney function:
  Creatinine, Urea, eGFR, Sodium - Important for detecting dehydration or reduced kidney function, which can be affected by rapid weight loss or medication side effects.
• Liver health:
  ALT, AST, ALP, GGT, Total Bilirubin, Albumin, Globulin, Total Protein - These markers monitor liver enzyme levels and protein balance, especially important as GLP-1 medications are processed by the liver and can impact liver function in some individuals.
• Lipid profile (cholesterol):
  Total Cholesterol, HDL, LDL, Triglycerides, HDL % - Weight-loss drugs often improve cholesterol levels, but these markers help track your cardiovascular risk as your weight changes.
• Blood sugar control:
  HbA1c - This long-term marker of glucose control is essential for those using GLP-1s for prediabetes, type 2 diabetes, or weight-related insulin resistance.
• Pancreatic health:
  Amylase, Lipase - Monitors enzymes that can be affected by GLP-1 medications, helping detect rare but serious side effects such as pancreatitis.

Who is this test for?

• Individuals currently using or planning to use GLP-1 weight-loss medications (e.g., Ozempic, Wegovy, Mounjaro)
• Those wishing to track treatment safety and effectiveness
• Patients advised by their GP or specialist to monitor organ function while on medication

Description provided by London Medical Laboratory.